Stryker (SYK) Cash from Financing Activities (2009 - 2026)

Stryker (SYK) reported Cash from Financing Activities of -$1.5 billion for Q1 2026, down 159.59% year-over-year from $2.5 billion in Q1 2025, and down 38.15% quarter-over-quarter from -$1.1 billion in Q4 2025.

Stryker (SYK) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Stryker (SYK) has 18 years of Cash from Financing Activities data on file, last reported at -$1.5 billion in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$1.5 billion, down 159.59% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.9 billion (down 261.97% YoY), and the FY2025 annual result was $113.0 million, up 121.52% from the prior year.
  • Cash from Financing Activities retreated to -$1.5 billion in Q1 2026 per SYK's latest filing, from -$1.1 billion in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $2.7 billion in Q3 2024 and troughed at -$1.8 billion in Q4 2024.
  • A 5-year average of -$250.9 million and a median of -$446.0 million in 2022 frame the typical range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 728.67% in 2024 and fell as far as 527.27% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$446.0 million in 2022, then soared by 35.87% to -$286.0 million in 2023, then sank by 527.27% to -$1.8 billion in 2024, then soared by 39.07% to -$1.1 billion in 2025, then tumbled by 38.15% to -$1.5 billion in 2026.
  • Business Quant data shows SYK's Cash from Financing Activities at -$1.5 billion in Q1 2026, -$1.1 billion in Q4 2025, and -$339.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -369.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.51 Bn
Mar 31, 2026 -1.51 Bn
Dec 31, 2025 -1.09 Bn
Dec 31, 2025 -1.09 Bn
Sep 30, 2025 -339.00 Mn
Sep 30, 2025 -339.00 Mn
Jun 30, 2025 -989.00 Mn
Jun 30, 2025 -989.00 Mn
Mar 31, 2025 2.53 Bn
Mar 31, 2025 2.53 Bn
Dec 31, 2024 -1.79 Bn
Dec 31, 2024 -1.79 Bn
Sep 30, 2024 2.65 Bn
Sep 30, 2024 2.65 Bn
Jun 30, 2024 -966.00 Mn
Jun 30, 2024 -966.00 Mn
Mar 31, 2024 -418.00 Mn
Mar 31, 2024 -418.00 Mn
Dec 31, 2023 -286.00 Mn
Dec 31, 2023 -286.00 Mn